Apolipoprotein E Pittsburgh variant is not associated with the risk of late-onset Alzheimer's disease in a Spanish population

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 120 B, Issue 1, 2003, Pages 121-124

  Baron, Manuel ^a   Jimenez Escrig, A ^b   Orensanz, L ^b   Simon, J ^b   Perez Tur, J ^c  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

^c INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

Alzheimer disease; Apolipoprotein E genetics; Genetic association studies

Indexed keywords

APOLIPOPROTEIN E;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; ARTICLE; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; ONSET AGE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION MAPPING; RISK ASSESSMENT; SPAIN;

MARTES PENNANTI;

EID: 0041321068     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.20028     Document Type: Article

References (15)

1. Bird TD, Jarvik GP, Wood NW. 2001. Genetic association studies: Genes in search of diseases. Neurology 57:1153-1154.
2. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA. 1993. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261:921-923.
3. Duara R, Lopez Alberola RF, Barker WW, Loewenstein DA, Zatinsky M, Eisdorfer CE, Weinberg GB. 1993. A comparison of familial and sporadic Alzheimer's disease. Neurology 43:1377-1384.
4. Fullerton SM, Clark AG, Weiss KM, Nickerson DA, Taylor SL, Stengard JH, Salomaa V, Vartiainen E, Perola M, Boerwinkle E, Sing CF. 2000. Apolipoprotein E variation at the sequence haplotype level: Implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet 67:881-900.
5. Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31:545-548.
6. Kamboh MI, Aston CE, Perez-Tur J, Kokmen E, Ferrell RE, Hardy J, DeKosky ST. 1999. A novel mutation in the apolipoprotein E gene (APOE*4 Pittsburgh) is associated with the risk of late-onset Alzheimer's disease. Neurosci Lett 263:129-132.
7. Mahley RW. 1988. Apolipoprotein E: Cholesterol transport protein with expanding role in cell biology. Science 240:622-630.
8. Myers RH, Schaefer EJ, Wilson PW, D'Agostino R, Ordovas JM, Espino A, Au R, White RF, Knoefel JE, Cobb JL, McNulty KA, Beiser A, Wolf PA. 1996. Apolipoprotein E epsilon4 association with dementia in a population-based study: The Framingham study. Neurology 46:673-677.
9. Orth M, Weng W, Funke H, Steinmetz A, Assmann G, Nauck M, Dierkes J, Ambrosch A, Weisgraber KH, Mahley RW, Wieland H, Luley C. 1999. Effects of a frequent apolipoprotein E isoform, ApoE4Freiburg (Leu28 → Pro), on lipoproteins and the prevalence of coronary artery disease in whites. Arterioscler Thromb Vasc Biol 19:1306-1315.
10. Perez-Tur J. 2000. La genética y la enfermedad de Alzheimer. Rev Neurol 30:161-169.
11. Refolo LM, Pappolla MA, Malester B, LaFrancois J, Bryant-Thomas T, Wang R, Tint GS, Sambamurti K, Duff K. 2000. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model. Neurobiol Dis 7:321-331.
12. Sham PC, Cherny SS, Purcell S, Hewitt JK. 2000. Power of linkage versus association analysis of quantitative traits, by use of variance-components models, for sibship data. Am J Hum Genet 66:1616-1630.
13. Strittmatter WJ, Weisgraber KH, Huang DY, Dong LM, Salvesen GS, Pericak-Vance M, Schmechel D, Saunders AM, Goldgaber D, Roses AD. 1993. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc Natl Acad Sci USA 90:8098-8102.
14. Wallace DM. 1987. Large- and small-scale phenol extractions. Methods Enzymol 152:33-41.
15. Weisgraber KH, Mahley RW. 1996. Human apolipoprotein E: The Alzheimer's disease connection. FASEB J 10: 1485-1494.